Pharmaceutical 3868 articles

Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.

Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.

People with genetically high cholesterol at lower risk of type 2 diabetes


Cholesterol-lowering statin drugs are prescribed to lower cholesterol levels in order to prevent heart attacks and strokes. But recent studies show that people who take these drugs are at an increased risk of developing type 2 diabetes, a condition that can lead to serious health problems including heart disease, kidney disease, cancer, dementia and blindness. Determining who should take statins can be a crapshoot considering the statin side effects. But a study published recently in JAMA offers reassurance to at least one segment of the population. It found that people who have a genetic form of high cholesterol are less ... Read More

Clinical trial to test new combination melanoma treatments


The ECOG-ACRIN Cancer Research Group will soon be recruiting patients with melanoma at cancer centers nationwide to participate in a study comparing the sequencing of two groups of effective melanoma treatments. The research is led by Georgetown University Medical Center physician Michael B. Atkins. “After many years of research, we’ve ended up with exciting and effective new combination treatment regimens. Now we need to figure out how to sequence these treatment regimens in order to best extend the lives of our patients,” he said. The study involves a combination of the drugs dabrafenib and trametinib, which work by directly attacking ... Read More

Victoza being tested as a treatment for nonalcoholic fatty liver disease


The type 2 diabetes drug Victoza can help resolve a type of nonalcoholic fatty liver disease in overweight patients, according to a new study presented at the 2015 International Liver Congress. The specific nonalcoholic fatty liver disease is called nonalcoholic steatohepatitis, or NASH. It is a common, often “silent” liver disease that resembles alcoholic liver disease but occurs in people who drink little or no alcohol. The major feature with NASH is fat in the liver, along with inflammation and damage. Most people are not aware they have a liver problem. However, it can become severe and lead to cirrhosis, ... Read More

Congressman Burgess defends controversial power morcellators


Texas Congressman Michael Burgess, a former gynecologist, is defending the use of controversial power morcellators for hysterectomies and uterine fibroid removals despite the risk of spreading cancer and worsening a woman’s odds of survival. Power morcellators are surgical tools fitted with a long tube-like blade that shreds entire uteruses or uterine growths inside the uterine cavity and removes them through a small incision in the abdomen. The procedures have been favored by many doctors over open surgeries because they are less invasive, leave less scar tissue, and offer shorter recovery. In recent years, the safety of the devices has come under ... Read More

Testosterone ineffective as treatment for ejaculatory dysfunction

Low T

Testosterone replacement therapy doesn’t benefit men with ejaculatory dysfunction, according to a study published in the July 9 issue of The Journal of Clinical Endocrinology & Metabolism. Testosterone treatments are used to increase the hormone levels in men with hypogonadism, a condition in which men do not produce enough testosterone due to injury or disease. The condition can cause symptoms such as low sex drive, muscle loss and fatigue. Ejaculatory dysfunction includes conditions such as delayed ejaculation, premature ejaculation and anejaculation. There is limited data to indicate whether testosterone deficiency may be a contributor to ejaculatory dysfunction in men. But ... Read More

Researchers explain reason for melanoma risk with Viagra


A new study published in the Journal of the American Medical Association warns that men who use the erectile dysfunction drug Viagra are twice as likely to develop the deadly skin cancer melanoma than men who did not use the drug. The study involved 25,000 male health professionals who were followed for 10 years. Researchers noted which men developed melanoma or other skin cancers, and whether they took Viagra. They found men who used or had ever used Viagra were at an increased risk of melanoma, but not other cancers such as basal cell carcinoma or squamous cell carcinoma. The ... Read More

Risperdal linked to prolonged erections, gynecomastia


The antipsychotic drug Risperdal has been associated with prolonged erections. The unwanted, persistent erection of the penis not caused by sexual stimulation or arousal is generally painful, and requires immediate medical attention. The side effect is so rare that doctors are not required to discuss it with patients who are prescribed the drug. But the Physicians’ Desk Reference lists reports of prolonged erections in patients treated with the meds. Risperdal, known generically as risperidone, is an antipsychotic drug used to treat adults and children with schizophrenia, bipolar disorder, and irritability with autism. It is sometimes used off-label to treat ADD, ... Read More

Kim Kardashian promotes controversial morning sickness drug

Kim Kardashian Diclegis - Instagram image

Kim Kardashian is profiting from her pregnancy by pushing a controversial morning sickness drug. Kardashian posted on Instagram a photo of herself with a bottle of Diclegis and a rather scripted message saying that her doctor prescribed the drug. “I’m so excited and happy with my results that I’m partnering with Duchesnay USA to raise awareness about treating morning sickness,” she writes. Diclegis is a combination of vitamin B6 and the antihistamine doxylamine. It is a delayed-release pill that is designed to be taken every day before symptoms occur. Nausea and vomiting associated with pregnancy generally occur in the morning, ... Read More

More patients being treated for atrial fibrillation


More patients than ever are being treated with blood thinners for the common irregular heart rhythm condition atrial fibrillation, thanks in part to direct-to-consumer advertising from the newest anticoagulants on the market. According to a study conducted by researchers with the University of Michigan Frankel Cardiovascular Center, doctors prescribed more than 2.83 million blood thinners in the last quarter of 2014, up about 800,000 from the start of 2009. Blood thinners are used to prevent strokes in patients with atrial fibrillation. They are also used to prevent or treat blood clots in the legs and lungs, a condition known as ... Read More

Johnson & Johnson announces declining sales in all three divisions


Consumer health care giant Johnson & Johnson recently reported concerning second-quarter earnings with overall sales down 8.8 percent from the same quarter last year. Some of the blame falls on the company’s medical devices division, which saw declining sales for the fourth straight quarter with not much hope for growth on the horizon, according to analysts. All three of Johnson & Johnson’s divisions – consumer products, medical devices, and pharmaceuticals – have experienced quarterly declines for the past few years. The majority of the declines were attributed to foreign exchange fluctuations, but sales in each division were weak. Declines in the company’s ... Read More